1. Home
  2. OC vs ABVX Comparison

OC vs ABVX Comparison

Compare OC & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Owens Corning Inc New

OC

Owens Corning Inc New

HOLD

Current Price

$122.10

Market Cap

9.3B

Sector

Industrials

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$116.19

Market Cap

9.0B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
OC
ABVX
Founded
1938
2013
Country
United States
France
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.3B
9.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OC
ABVX
Price
$122.10
$116.19
Analyst Decision
Buy
Strong Buy
Analyst Count
13
12
Target Price
$148.08
$118.33
AVG Volume (30 Days)
1.2M
1.9M
Earning Date
02-23-2026
08-11-2025
Dividend Yield
2.70%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,659,000,000.00
$6,231,374.00
Revenue This Year
N/A
$6.80
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.69
N/A
52 Week Low
$97.53
$4.77
52 Week High
$192.96
$148.83

Technical Indicators

Market Signals
Indicator
OC
ABVX
Relative Strength Index (RSI) 64.84 44.18
Support Level $110.00 $108.95
Resistance Level $117.80 $129.56
Average True Range (ATR) 3.30 7.90
MACD 0.66 -2.73
Stochastic Oscillator 96.83 18.66

Price Performance

Historical Comparison
OC
ABVX

About OC Owens Corning Inc New

Owens-Corning Inc is a manufacturer of glass fiber utilized in composites and building materials. It has an integrated business model with four reportable segments: Composites, Insulation, Doors, and Roofing. It generates maximum revenue from the Roofing segment. Its Roofing segment laminate and strip asphalt roofing shingles, roofing components, synthetic packaging materials, and oxidized asphalt. It meets the growing demand for longer-lasting, aesthetically attractive laminate products with modest capital investment. Geographically the company generates the majority of its revenue from the United States.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: